Aloxi

 

Topic mentions per year

Topic mentions per year

2003-2016
012320032016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
 
Is this relevant?
Review
2010
Review
2010
Chemotherapy and radiotherapy-induced nausea and vomiting are frequent, unpleasant side effects of cancer treatment. Serotonin… (More)
  • table 1
Is this relevant?
Review
2007
Review
2007
Chemotherapy-induced nausea and vomiting (CINV) remains an important and common toxicity of cancer treatment. Recent guideline… (More)
Is this relevant?
2006
2006
In July 2003, the Food and Drug Administration approved palonosetron hydrochloride injection for the treatment of chemotherapy… (More)
Is this relevant?
2006
2006
  • 2006
DESCRIPTION Aloxi (palonosetron hydrochloride) is an antiemetic and antinauseant agent. It is a selective serotonin subtype 3 (5… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2006
Review
2006
Nausea and vomiting are considered to be among the most distressing consequences of cytotoxic chemotherapies. Currently, there… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Palonosetron (Aloxi, Onicit) is a selective 5-HT(3) receptor antagonist recently approved by the Food and Drug Administration for… (More)
Is this relevant?
2004
2004
The purpose of this study was to evaluate the physical and chemical stability of palonosetron hydrochloride 0.25 mg admixed with… (More)
Is this relevant?
Review
2004
Review
2004
Nausea and vomiting are typical side effects of cytotoxic therapy and some surgical procedures. These symptoms can represent a… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Review
2003
Review
2003
Palonosetron (Aloxi) is a 5-HT(3)-receptor antagonist antiemetic indicated for the prevention of acute and delayed nausea and… (More)
Is this relevant?